What You Should Know: 2bPrecise, a precision medicine company, announced that the US Orthopedic Alliance (USOA) is leveraging 2bPrecise’ pharmacogenomics (PGx) solution to help physicians identify potentially dangerous drug-gene interactions. - The 2bPrecise platform will deliver workflow, data management and clinical decision functionality to USOA providers ordering pharmacogenomic tests (PGx). Specifically, doctors can leverage test results to make informed decisions
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
PHINs: Addressing the Fundamental Flaws that Have Broken Healthcare
The fundamental problem with healthcare can be summed up in one sentence: We expect healthcare services that cater to our individual needs, yet the health care system operates under a one-size-fits-all, trial-and-error model. It is a model that results in missed diagnoses, protracted illnesses, and even premature death and wastes $935 billion annually. The financial toll of this outmoded approach pales in comparison to the human toll. More than 128,000 people in the U.S. die each year
Read More
Cardinal Health and Deep Lens Collaborate for AI-based Oncology Clinical Trial Matching
What You Should Know: - Today, Deep Lens and Cardinal Health announced a strategic collaboration that will integrate Deep Lens’ AI-based clinical trial matching solution, VIPER, into community-based oncology practices throughout the Cardinal network. VIPER will be a part of Cardinal Health’s new Navista advanced suite of technology solutions designed to help oncologists improve outcomes, provide high quality care at the best possible cost and select the right care plan at the onset of
Read More
Biospecimen Procurement for R&D Needs to Look More Like an Online Marketplace
As healthcare digitizes everything from insurance claims to clinical decisions, some functions remain frustratingly analog, old school, and inefficient. One such function is the distribution of human biospecimens necessary for medical research. Specimens are essential in providing much of the data that researchers examine, EHRs capture, and scientific databases aggregate. Unfortunately, the distribution of specimens and their data to researchers is woefully outdated and inefficient. Frankly,
Read More
Syapse Lands $68M to Expand Global Precision Oncology Data Sharing Network
What You Should Know: - Syapse raises 68M in equity investment led by Ally Bridge Group (ABG), with Northpond Ventures to expand delivery of real-world evidence through Syapse’s Learning Health Network. - The Syapse Learning Health Network is a global precision oncology data sharing network, improving cancer care across communities by using real-world data to support clinical decisions. Syapse, a San Francisco, CA-based real-world evidence company accelerating the delivery
Read More
Frenova Begins Patient Enrollment to Build World’s Largest Genomics Registry for Kidney Disease
What You Should Know: - Frenova Renal Research, a global division of Fresenius
Medical Care, announced today that it has started to enroll patients in its
new endeavor to build the world’s largest genomics registry targeting kidney
disease. - The registry will be used to help advance understanding
of the genetic drivers of kidney disease and shape more precise, individualized
therapies. Fresenius
Medical Care, the world’s leading provider of products and services for
people
Read More
Meaningful Use of Genomics Requires Informatics Beyond EMRs
Electronic medical records (EMRs) are widely expected to serve as a cornerstone technology that drives the delivery of modern patient care. But can the EMR alone support all the informatics capabilities required by an ever-evolving healthcare industry? The rapid growth of precision medicine, particularly the use of genetic and genomic information during clinical decision making, is a compelling example that functionality beyond the EMR is required. Not only does genomic data represent a
Read More
Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders
Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. Currently, these products are often expensive because they target specific conditions and cost on average $147,000 or more per year, making commercialization
Read More
VHA Innovation Ecosystem Taps MDClone to Leverage Synthetic Data for Faster Healthcare to Veterans
What You Should Know: - Data analytics and digital health company MDClone
announced a partnership with the Department of Veterans Affairs’ (VA) VHA
Innovation Ecosystem to democratize data and provide better, smarter, faster
healthcare to U.S Veterans. - By leveraging MDClone’s data platform, the VHA is able to tackle this massive problem by securely accessing, organizing, and analyzing the critical health data of Veterans with the use of synthetic data – a breakthrough method pioneered
Read More
Amazon Launches HealthLake for Healthcare Orgs to Aggregate & Structure Health Data
What You Should Know: - Amazon today announced the launch of Amazon HealthLake,
a new HIPAA-eligible service enables healthcare organizations to store, tag,
index, standardize, query, and apply machine learning to analyze data at
petabyte scale in the cloud. - Cerner, Ciox Health, Konica Minolta Precision Medicine,
and Orion Health among customers using Amazon HealthLake. Today at AWS re:Invent, Amazon
Web Services, Inc. (AWS), an Amazon.com company today announced Amazon
Read More
